on 17 Jan 2025
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2274275 filed on 20th Apr 2023
Registration Number
TMA1285052 registered on 17th Jan 2025
Registration expiry Date
15th Mar 2033Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les m Read More12
2274275
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 256 on 12th Aug 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 210 on 12th Oct 2023 | IR Correction |
Submitted for opposition 257 on 12th Oct 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 210 on 14th Sept 2023 | IR Correction |
Submitted for opposition 257 on 14th Sept 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 257 on 10th Aug 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 9th Aug 2023 | Created |
Submitted for opposition 31 on 9th Aug 2023 | Formalized |
Submitted for opposition 30 on 20th Apr 2023 | Filed |
Submitted for opposition 228 on 15th Mar 2023 | International Registration |